Mosquito-borne transmission of the Zika virus appeared in South Florida just recently, but UHealth physicians are already busy counseling prospective parents and treating pregnant women, and UM scientists are working overtime to bring diagnostic and therapeutic responses from the laboratory to the clinic — some possibly by the end of this year.
Renal Pathology ServiceMore info
40th REVIEW AND ADVANCES IN PATHOLOGYMore info
Among the Nation’s BestLearn More
Dedicated to Providing Quality Patient CareLearn More
Providing the Highest Quality EducationLearn More
A Phase I dose-escalation trial, conducted at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and multiple sites nationwide, has shown that a new gene therapy treatment for high-grade gliomas — the most aggressive brain tumors — is safe and improves patient survival. Having passed this milestone, the treatment will move on to more advanced trials.
Continuing an upward trend, the University of Miami Miller School of Medicine reached a record-breaking fundraising total for the fiscal year 2016. According to standards set by the Council for Advancement and Support of Education (CASE), the Miller School raised an unprecedented $159.8 million for the fiscal year, which ended May 31.